• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Sanofi

Mice playing around tubes in a rack in the lab
CRO

Big Pharma-backed program seeks future beyond animal testing

The Validation and Qualification Network brings together regulators like the FDA with companies like Sanofi, Novo Nordisk, GSK and Charles River.
Darren Incorvaia Aug 1, 2025 5:00pm
Sanofi

Sanofi pens $395M China pact for Arrowhead metabolic med

Aug 1, 2025 7:21am
Brain wrapped in cash money

MapLight raises $373M to plot phase 2 journey for Cobenfy rival

Jul 28, 2025 10:23am
Graphic of a one dollar bill with nuts and bolts scattered across it

Sanofi inks $1.15B buyout to boost RSV pipeline

Jul 22, 2025 4:20am
graphic art of a right hand signing something

Sanofi takes up option on Adagene bispecific, invests $25M

Jul 1, 2025 8:10am
positive negative up down good bad mixed

Kymera suffers Sanofi setback but secures $750M Gilead deal

Jun 25, 2025 9:31am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings